Metral
Markets

Cancer drug startup Parabilis Medicines is raising a record $670 million in its IPO

The Cambridge, Massachusetts-based biotech priced 33.5 million shares at $20 each, topping the $625 million raised by Kailera Therapeutics in April

M
Metral Newsroom
Editorial Desk
· 2 min read
𝕏 in ✉
Cancer drug startup Parabilis Medicines is raising a record $670 million in its IPO

Cancer drug startup Parabilis Medicines is raising a record $670 million in its IPO

Published June 10, 2026 · Category: Markets

Overview

The Cambridge, Massachusetts-based biotech priced 33.5 million shares at $20 each, topping the $625 million raised by Kailera Therapeutics in April

Source

Originally published at qz.com.

Related Articles

CD
Metral Newsroom

Metral covers global markets, stocks, crypto and the economy — desk research and data-driven analysis. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.

Related Stories

More from Financial News →
Micron ties its future to Anthropic in supply deal
Markets

Micron ties its future to Anthropic in supply deal
Oil prices fall after US waives Iran sanctions and peace talks in Switzerland progress – business live
Markets

Oil prices fall after US waives Iran sanctions and peace talks in Switzerland progress – business live
Australia's coal and gas exports violate our human rights, group says in new UN case
Markets

Australia's coal and gas exports violate our human rights, group says in new UN case
Amazon is selling a 2-in-1 laptop and tablet for just $73 during Prime Day
Markets

Amazon is selling a 2-in-1 laptop and tablet for just $73 during Prime Day